Summary
The product Testosterone Enanthate 250 mg/ml, manufactured by PrimePharma, was analyzed for its composition and dosage accuracy. The sample, identified by batch number PP1758, was submitted by the reseller Opitropin.EU and tested by Janoshik Analytical, a well-regarded laboratory for pharmaceutical quality analysis. The results confirmed the presence of Testosterone Enanthate at a concentration of 258.31 mg/ml, exceeding the labeled claim of 250 mg/ml by 3.32%.
Testing was initiated on 2 May 2023, with the sample received on 11 May 2023, and the analysis completed on 15 May 2023. Reseller-submitted samples often warrant a higher degree of scrutiny, as resellers may provide selectively chosen batches for testing. Additional independent validation is recommended to assess consistency across multiple production lots.
This report serves to provide educational insights and advance harm reduction in the anabolic steroid market.
Detailed Report
Product Overview
- Manufacturer: PrimePharma
- Product Name: Testosterone Enanthate 250 mg/ml
- Active Ingredient: Testosterone Enanthate
- Batch Number: PP1758
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #29394
- Testing Ordered: 2 May 2023
- Sample Received: 11 May 2023
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Labeled Specification: 250 mg/ml
- Measured Concentration: 258.31 mg/ml
- Accuracy: 103.32% (3.32% above the label claim)
Verification Details:
- Verification URL: https://janoshik.com/tests/29394_FZDFNJ7PVHPC
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
The reported results indicate that Testosterone Enanthate 250 mg/ml is slightly overdosed, with a concentration exceeding its label claim. However, as the sample was both submitted and funded by the reseller Opitropin.EU, it is prudent to scrutinize the results. Resellers may submit optimal batches for analysis, potentially skewing the representation of the product’s overall quality and consistency.
Janoshik Analytical is recognized for its rigorous testing protocols, which add credibility to the findings. Nevertheless, independent third-party testing is encouraged to further validate these results and ensure broader consumer confidence in the product’s consistency across different batches.
Conclusion
The analysis of Testosterone Enanthate 250 mg/ml demonstrates that the product is slightly overdosed at 258.31 mg/ml, reflecting a 3.32% variance above the labeled specification. These results suggest high quality in this particular batch, although independent validation is recommended to confirm consistency across other production lots. This report supports educational initiatives and harm reduction by providing transparent, data-driven insights into the product’s quality.
Disclaimer: This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
